Daniel N. Swisher, Jr
2009 - Sunesis Pharmaceuticals
In 2009, Daniel N. Swisher, Jr earned a total compensation of $653.4K as CEO and President at Sunesis Pharmaceuticals, a 62% increase compared to previous year.
Compensation breakdown
| Option Awards | $241,950 |
|---|---|
| Salary | $405,000 |
| Other | $6,450 |
| Total | $653,400 |
Swisher received $405K in salary, accounting for 62% of the total pay in 2009.
Swisher also received $242K in option awards and $6.5K in other compensation.
Rankings
In 2009, Daniel N. Swisher, Jr's compensation ranked 5,921st out of 9,885 executives tracked by ExecPay. In other words, Swisher earned more than 40.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,921 out of 9,885 | 40th |
Division Manufacturing | 2,137 out of 3,690 | 42nd |
Major group Chemicals And Allied Products | 457 out of 871 | 48th |
Industry group Drugs | 302 out of 643 | 53rd |
Industry Pharmaceutical Preparations | 222 out of 446 | 50th |
Source: SEC filing on April 21, 2011.
Swisher's colleagues
We found three more compensation records of executives who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2009.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019